Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. Prospective Phase III Study

NCT02971696 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT02971696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02971696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. Prospective Phase III Study
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2016
Completion date
January 31, 2018
Enrollment
55 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hcc